UM

Browse/Search Results:  1-10 of 11 Help

Selected(0)Clear Items/Page:    Sort:
Ursolic Acid Attenuates Atherosclerosis in ApoE(-/-) Mice: Role of LOX-1 Mediated by ROS/NF-B Pathway Journal article
Li, Qiu, Zhao, Wenwen, Zeng, Xi, Hao, Zhihui. Ursolic Acid Attenuates Atherosclerosis in ApoE(-/-) Mice: Role of LOX-1 Mediated by ROS/NF-B Pathway[J]. MOLECULES, 2018, 23(5).
Authors:  Li, Qiu;  Zhao, Wenwen;  Zeng, Xi;  Hao, Zhihui
Favorite | TC[WOS]:28 TC[Scopus]:37  IF:4.2/4.6 | Submit date:2018/10/30
Atherosclerosis  Ros  Huvecs  Lox-1  
Dihydrotanshinone I attenuates atherosclerosis in ApoE-deficient mice: Role of NOX4/NF-κB mediated lectin-like oxidized LDL receptor-1 (LOX-1) of the Endothelium Journal article
Zhao W., Li C., Gao H., Wu Q., Shi J., Chen X.. Dihydrotanshinone I attenuates atherosclerosis in ApoE-deficient mice: Role of NOX4/NF-κB mediated lectin-like oxidized LDL receptor-1 (LOX-1) of the Endothelium[J]. Frontiers in Pharmacology, 2016, 7(NOV).
Authors:  Zhao W.;  Li C.;  Gao H.;  Wu Q.;  Shi J.; et al.
Favorite | TC[WOS]:45 TC[Scopus]:52 | Submit date:2018/12/28
Atherosclerosis  Danshen  Lipopolysaccharide  Lox-1  Ros  
Cryptotanshinone inhibits TNF-α-induced LOX-1 expression by suppressing reactive oxygen species (ROS) formation in endothelial cells Journal article
Ran X., Zhao W., Li W., Shi J., Chen X.. Cryptotanshinone inhibits TNF-α-induced LOX-1 expression by suppressing reactive oxygen species (ROS) formation in endothelial cells[J]. Korean Journal of Physiology and Pharmacology, 2016, 20(4), 347-355.
Authors:  Ran X.;  Zhao W.;  Li W.;  Shi J.;  Chen X.
Favorite | TC[WOS]:18 TC[Scopus]:16 | Submit date:2018/12/28
Cryptotanshinone  Endothelial Cells  Lox-1  Ros  Tnf-α  
Regulation of Coronary Endothelial Function by Interactions between TNF-α, LOX-1 and Adiponectin in Apolipoprotein e Knockout Mice Journal article
Chen,Xiuping, Zhang,Hanrui, Hill,Michael A., Zhang,Cuihua, Park,Yoonjung. Regulation of Coronary Endothelial Function by Interactions between TNF-α, LOX-1 and Adiponectin in Apolipoprotein e Knockout Mice[J]. Journal of Vascular Research, 2016, 52(6), 372-382.
Authors:  Chen,Xiuping;  Zhang,Hanrui;  Hill,Michael A.;  Zhang,Cuihua;  Park,Yoonjung
Favorite | TC[WOS]:8 TC[Scopus]:9  IF:1.8/1.7 | Submit date:2021/03/01
Adiponectin  Endothelial Dysfunction  Lox-1  Tnf-α  
Regulation of Coronary Endothelial Function by Interactions between TNF-α, LOX-1 and Adiponectin in Apolipoprotein e Knockout Mice Journal article
Chen X., Zhang H., Hill M.A., Zhang C., Park Y.. Regulation of Coronary Endothelial Function by Interactions between TNF-α, LOX-1 and Adiponectin in Apolipoprotein e Knockout Mice[J]. Journal of Vascular Research, 2016, 52(6), 372-382.
Authors:  Chen X.;  Zhang H.;  Hill M.A.;  Zhang C.;  Park Y.
Favorite | TC[WOS]:8 TC[Scopus]:9 | Submit date:2018/12/28
Adiponectin  Endothelial Dysfunction  Lox-1  Tnf-α  
Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-κB pathway Journal article
Zhao W., Ma G., Chen X.. Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-κB pathway[J]. Vascular Pharmacology, 2014, 63(3), 162.
Authors:  Zhao W.;  Ma G.;  Chen X.
Favorite | TC[WOS]:54 TC[Scopus]:62 | Submit date:2018/10/30
Endothelial Cells  Lipopolysaccharide  Lox-1  Ros  
Ox-LDL-induced LOX-1 expression in vascular smooth muscle cells: Role of reactive oxygen species Journal article
Sun Y., Chen X.. Ox-LDL-induced LOX-1 expression in vascular smooth muscle cells: Role of reactive oxygen species[J]. Fundamental and Clinical Pharmacology, 2011, 25(5), 572.
Authors:  Sun Y.;  Chen X.
Favorite | TC[WOS]:37 TC[Scopus]:46 | Submit date:2018/10/30
Lox-1  Ros  Vascular Smooth Muscle Cells  Atherosclerosis  
The reciprocal relationship between adiponectin and LOX-1 in the regulation of endothelial dysfunction in ApoE knockout mice Journal article
Chen X., Zhang H., McAfee S., Zhang C.. The reciprocal relationship between adiponectin and LOX-1 in the regulation of endothelial dysfunction in ApoE knockout mice[J]. American Journal of Physiology - Heart and Circulatory Physiology, 2010, 299(3).
Authors:  Chen X.;  Zhang H.;  McAfee S.;  Zhang C.
Favorite | TC[WOS]:34 TC[Scopus]:38 | Submit date:2018/12/28
Lox-1  Ros  Atherosclerosis  Vasorelaxation  Oxidative Stress  
Advanced glycation end products serve as ligands for lectin-like oxidized low-density lipoprotein receptor-1(LOX-1): biochemical and binding characterizations assay. Journal article
Chen X., Zhang T., Du G.. Advanced glycation end products serve as ligands for lectin-like oxidized low-density lipoprotein receptor-1(LOX-1): biochemical and binding characterizations assay.[J]. Cell biochemistry and function, 2008, 26(7), 760-770.
Authors:  Chen X.;  Zhang T.;  Du G.
Favorite | TC[WOS]:21 TC[Scopus]:26 | Submit date:2018/12/28
Ages  Lox-1  Atherosclerosis  
Lectin‐like Oxidized Low‐density Lipoprotein Receptor‐1, a New Promising Target for the Therapy of Atherosclerosis? Journal article
Xiu‐Ping Chen, Tian‐Tai Zhang, Guan‐Hua Du. Lectin‐like Oxidized Low‐density Lipoprotein Receptor‐1, a New Promising Target for the Therapy of Atherosclerosis?[J]. Cardiovascular Drug Reviews, 2007, 25(2), 146-161.
Authors:  Xiu‐Ping Chen;  Tian‐Tai Zhang;  Guan‐Hua Du
Favorite | TC[WOS]:68 TC[Scopus]:72  IF:5.208/3.793 | Submit date:2019/01/08
Antiatherosclerotic Drugs  Atherosclerosis  Lox-1  Ox-ldl